Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Paco Bautista

Clinical scientist
  • Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia

    • jun. 2022
    • Edoardo, Pennesi, et al
    • Leukemia
  • Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies

    • nov. 2021
    • Francisco, Bautista, et al
    • Journal of Clinical Oncology
  • Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma

    • sep. 2021
    • Giuseppe, Barone, et al
    • Paediatric drugs
  • A phase 2 study of nilotinib in pediatric patients with CML

    • jul. 2021
    • Nobuko, Hijiya, et al
    • Blood Advances
  • Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe

    • dec. 2020
    • Alba, Rubio-San-Simón, et al
    • European Journal of Cancer
View all publications